Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy.
Pascual
J
J
Servicio de Nefrologia, Hospital Ramon y Cajal, Madrid, Spain.
Ortuño
J
J
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D002102:Cadaver; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology / Q000401:mortality; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D011183:Postoperative Complications / Q000453:epidemiology / Q000401:mortality; D013030:Spain; D015996:Survival Rate; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014019:Tissue Donors
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D002784:Cholesterol; D003404:Creatinine; D001379:Azathioprine; D016559:Tacrolimus